Bausch Health (NYSE: BHC) withholds 23,395 shares for RSU tax obligations

Rhea-AI Filing Summary

Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc., reported a tax-withholding disposition of 23,395 common shares on July 15, 2026 at $4.89 per share. The issuer withheld these shares to satisfy tax obligations on vested Restricted Share Units, leaving her with 376,940 common shares held directly.

Insider Trade Summary

Net Seller: 23,395 shares

Net Sell 1 txn

Insider Lenar Aimee J.

Role President, US Pharma

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares, No Par Value F1	23,395	$4.89	$114K

Holdings After Transaction: Common Shares, No Par Value — 376,940 shares (Direct)

Footnotes (1)

1. F1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

Key Figures

Shares withheld for taxes: 23,395 common shares Price per share: $4.89 Shares held after transaction: 376,940 common shares +2 more

5 metrics

Shares withheld for taxes 23,395 common shares Tax-withholding disposition on 2026-07-15 related to vesting of Restricted Share Units

Price per share $4.89 Per-share value applied to the 23,395 withheld common shares

Shares held after transaction 376,940 common shares Direct holdings of Aimee J. Lenar following the tax-withholding disposition

Tax-withholding transactions in this filing 1 Number of Form 4 tax-withholding dispositions reported for Aimee J. Lenar

Transaction date 2026-07-15 Date of the reported tax-withholding disposition of Bausch Health common shares

Key Terms

Restricted Share Units, tax withholding obligations, Common Shares, No Par Value

3 terms

Restricted Share Units financial

"withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units"

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

tax withholding obligations financial

"common shares withheld to satisfy the tax withholding obligations due upon vesting"

Common Shares, No Par Value financial

"security title listed as Common Shares, No Par Value of the issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 04:23 PM Accepted by SEC EDGAR 07/17/2026 - 04:23 PM Learn about SEC filing dates

FAQ

What transaction did Aimee J. Lenar report in Bausch Health (BHC)'s Form 4?

Aimee J. Lenar, President, US Pharma at Bausch Health, reported a tax-withholding disposition of 23,395 common shares on July 15, 2026. The issuer withheld these shares to satisfy tax obligations from vesting Restricted Share Units, rather than selling them in the open market.

How many Bausch Health (BHC) shares does Aimee J. Lenar hold after this Form 4 transaction?

After the reported tax-withholding transaction, Aimee J. Lenar directly holds 376,940 common shares of Bausch Health. This figure reflects her remaining direct ownership after 23,395 shares were withheld by the issuer to cover tax obligations tied to Restricted Share Unit vesting.

What price per share applied to the Bausch Health (BHC) tax-withholding shares?

The tax-withholding disposition used a price of $4.89 per common share for the 23,395 Bausch Health shares. This value represents the per-share price associated with the issuer’s withholding of shares to satisfy Aimee J. Lenar’s tax obligations on vested Restricted Share Units.

What type of security was involved in Aimee J. Lenar's Bausch Health (BHC) Form 4?

The transaction involved Common Shares, No Par Value of Bausch Health Companies Inc. These common shares were withheld by the issuer to cover tax obligations that arose when Aimee J. Lenar’s Restricted Share Units vested, rather than being acquired or sold in a market trade.

Was Aimee J. Lenar's Bausch Health (BHC) Form 4 transaction under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox was not marked, so this tax-withholding transaction was not reported as occurring under a Rule 10b5-1 trading plan. It reflects shares withheld by the issuer to satisfy tax obligations from Restricted Share Unit vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lenar Aimee J.

(Last) (First) (Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER NEW JERSEY 08807

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, US Pharma

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	07/15/2026		F		23,395(1)	D	$4.89	376,940	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.

	/s/ Brianna M. Dorsi, attorney-in-fact	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)